[5] Use of Lipo-C Injection is contraindicated in patients with known hypersensitivity to methionine, choline salts, carnitine, dexpanthenol, or any formulation excipients, as well as in individuals with severe hepatic failure in whom augmented methionine intake could precipitate hypermethioninemia and encephalopathy
Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor agonists Tirzepatide is a once-weekly, subcutaneous injectable peptide with dual agonist activity at both GLP-1 and GIP receptors
If youre exploring regenerative medicine, youve likely come across BPC-157, famous for its incredible tissue-healing abilities
Safety data is limited to the preclinical studies, where no adverse events were reported at therapeutic doses during the 11-week treatment period the longest published study duration
"Cellular senescence as a therapeutic target to improve renal transplantation outcome"